Sort
30,917 grants matching “tumor microenvironment”
Manipulating b1 integrin to enhance radiation therapy for breast cancer
$391,754Catherine C Park · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2010 · CA
Manipulating b1 integrin to enhance radiation therapy for breast cancer
$391,754Catherine C Park · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2008 · CA
TBEL Administrative Core
$391,733Angelo Michael De Marzo · Johns Hopkins University · U54 · FY2025 · CA
Multiplexed nanoparticle delivery to increase CRISPR/Cas gene editing for enhanced cancer therapy
$391,721Daniel John Siegwart · Ut Southwestern Medical Center · R01 · FY2025 · CA
Multiplexed nanoparticle delivery to increase CRISPR/Cas gene editing for enhanced cancer therapy
$391,721Daniel John Siegwart · Ut Southwestern Medical Center · R01 · FY2022 · CA
Increasing organoid reproducibility and complexity for drug testing and disease modeling
$391,703Zev Jordan Gartner · University Of California, San Francisco · R33 · FY2025 · CA
Role of microRNAs released by Tumor Associated Macrophages within Exosomes in the chemoresistance of Neuroblastoma
$391,698Muller Fabbri · Children'S Hospital Of Los Angeles · R01 · FY2017 · CA
Project 3: Inhibiting Oxidative Phosphorylation in Pancreatic Cancer
$391,697Shubham Pant · University Of Tx Md Anderson Can Ctr · P50 · FY2022 · CA
Personalizing immunotherapy in HER2+ breast cancer through quantitative imaging
$391,680Anna C Sorace · University Of Alabama At Birmingham · R01 · FY2021 · CA
An Engineered Tissue Model of Aged Mammary Microenvironment
$391,674Pinar Zorlutuna · University Of Notre Dame · R01 · FY2020 · EB
Retroviral RLI immunomodulatory gene therapy for glioblastoma
$391,638Manish Aghi · University Of California, San Francisco · R01 · FY2024 · NS
Molecular Analysis of OSCC Tumor Invasion
$391,581Bert W O'Malley · University Of Pennsylvania · R01 · FY2010 · DE
TCR-less Targeted T Cells Against Cancer
$391,529Michael W Fanger · Celdara Medical, Llc · R43 · FY2010 · CA
Preventing Melanoma Metastasis by Targeting Lipid Vulnerabilities in Lymph
$391,523Jessalyn Ubellacker · Harvard University D/B/A Harvard School Of Public Health · R01 · FY2025 · CA
Molecular mechanism by which Tim-3 induces T cell dysfunction and inhibits anti-t
$391,493Vijay K Kuchroo · Brigham And Women'S Hospital · P01 · FY2019 · AI
Elucidating the Role of Perivascular Niche in Glioblastoma Invasion and Therapeutic Resistance at Single Cell Resolution using Biomimetic Tumor Microenvironment Models
$391,489Mehdi Nikkhah · Arizona State University-Tempe Campus · R01 · FY2021 · NS
Selenium in gastrointestinal inflammatory diseases
$391,475Christopher S. Williams · Vanderbilt University · R01 · FY2015 · DK
The lymph node microenvionment in tumor metastasis
$391,453Judith A. Varner · University Of California, San Diego · R01 · FY2012 · CA
IDO2 Targeting in Pancreatic Cancer
$391,418George C Prendergast · Lankenau Institute For Medical Research · R01 · FY2018 · CA
IDO2 Targeting in Pancreatic Cancer
$391,418George C Prendergast · Lankenau Institute For Medical Research · R01 · FY2017 · CA
IDO2 Targeting in Pancreatic Cancer
$391,418George C Prendergast · Lankenau Institute For Medical Research · R01 · FY2016 · CA
Reprogramming the Tumor Microenvironment to Improve Immunotherapy of Glioblastoma by Co-Targeting VEGF and Ang2
$391,317Dai Fukumura · Massachusetts General Hospital · R01 · FY2024 · NS
ILT3 (LILRB4) in anti-tumor immunity and immunotherapy
$391,277Marco Colonna · Washington University · R21 · FY2024 · CA
Targeting tumor innate immune signaling in pancreatic cancer
$391,277Kian H Lim · Washington University · R01 · FY2025 · CA
Changing Contraceptive Patterns and Ovarian Cancer Risk
$391,252Kathryn L Terry · Brigham And Women'S Hospital · R01 · FY2025 · CA